Parker Albert P 4
4 · Zynerba Pharmaceuticals, Inc. · Filed Feb 15, 2022
Insider Transaction Report
Form 4
Parker Albert P
Chief Legal Officer
Transactions
- Award
Common Stock
2022-02-14+35,000→ 35,000 total - Award
Stock Option (right to buy)
2022-02-14+200,000→ 200,000 totalExercise: $2.70Exp: 2032-02-14→ Common Stock (200,000 underlying)
Footnotes (2)
- [F1]The restricted stock award vests in 3 equal annual installments on the first, second, and third anniversaries of the date of grant, beginning on February 14, 2023.
- [F2]The stock option vests 25% on the first anniversary of the date of the grant, with the remainder vesting in 12 equal quarterly installments thereafter, subject to continued employment with the Company through the applicable vesting date.